Yew Bio-Pharm Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Guifang Qi

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	9.9yrs
CEO ownership	n/a
Management average tenure	no data
Board average tenure	8.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Guifang Qi's remuneration changed compared to Yew Bio-Pharm Group's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2021	n/a	n/a	US$403k
Jun 30 2021	n/a	n/a	US$3m
Mar 31 2021	n/a	n/a	US$4m
Dec 31 2020	US$70k	US$70k	US$1m
Sep 30 2020	n/a	n/a	-US$127k
Jun 30 2020	n/a	n/a	US$61k
Mar 31 2020	n/a	n/a	US$760k
Dec 31 2019	US$70k	US$70k	US$986k
Sep 30 2019	n/a	n/a	US$293k
Jun 30 2019	n/a	n/a	-US$1m
Mar 31 2019	n/a	n/a	-US$1m
Dec 31 2018	US$70k	US$70k	-US$1m
Sep 30 2018	n/a	n/a	-US$6m
Jun 30 2018	n/a	n/a	-US$5m
Mar 31 2018	n/a	n/a	US$3m
Dec 31 2017	US$70k	US$70k	US$3m
Sep 30 2017	n/a	n/a	US$10m
Jun 30 2017	n/a	n/a	US$10m
Mar 31 2017	n/a	n/a	US$1m
Dec 31 2016	US$70k	US$70k	US$2m

Compensation vs Market: Insufficient data to establish whether Guifang's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Guifang's compensation with company performance.

CEO

Guifang Qi (61 yo)

9.9yrs

Tenure

US$69,600

Compensation

Madame. Guifang Qi serves as Secretary of Bio-Pharm Group, Inc since December 15, 2013 and also serves as its Chief Executive Officer, Chief Financial Officer, President and Chairman of the Board since Jul...

Board Members

Name	Position	Tenure	Compensation	Ownership
Guifang Qi	CEO, CFO	12.9yrs	US$69.60k	no data
Xuehai Wu	Director	8.2yrs	no data	no data
Hailong Sun	Independent Director	4.1yrs	no data	no data

8.2yrs

Average Tenure

50yo

Average Age

Experienced Board: YEWB's board of directors are considered experienced (8.2 years average tenure).